These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5265955)

  • 21. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of 3-(methyl-hydroxyethylamino)-2 hydroxypropyltheophylline nicotinate on hemodynamics of the systemic and pulmonary circulation in normal subjects and patients with mitral stenosis].
    Filocamo G; Giuffrida G; Basile U; Parrinello A; Bellisario G; Pugliese F
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:2121-3. PubMed ID: 5876720
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of local vasodilatation on blood flow through arterial stenosis. A theoretical analysis of the pressure-flow dynamics.
    Kreuzer W; Schenk WG
    Eur Surg Res; 1973; 5(3):233-42. PubMed ID: 4748905
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Decrease of pressure in pulmonary arteries by drugs following pneumoresection].
    Hartel W; Lenz J; Schuster G
    Langenbecks Arch Chir; 1969; 325():889-92. PubMed ID: 5372408
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of aminophylline on pulmonary hypertension].
    Harzbecker K
    Z Erkr Atmungsorgane; 1984; 163(1):6-13. PubMed ID: 6435320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasodilator drugs in chronic obstructive airways disease.
    Howard P
    Eur Respir J Suppl; 1989 Jul; 7():678s-681s. PubMed ID: 2679615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology of the pulmonary circulation].
    Follath F
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1328-32. PubMed ID: 2866581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pressure in the right heart portions and in the pulmonary artery system during lung resection].
    Sokolov EA; Strelets BM
    Vestn Khir Im I I Grek; 1973 Jul; 111(7):19-20. PubMed ID: 4776757
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute effect of xanthinol nicotinate on cutaneous and intramuscular temperature in diabetic patients].
    Berezovsky MR; Berstein S; Lopez Morillas AM; Novoa FC; Acuña E; Reitich GE; Gottlieb S
    Prensa Med Argent; 1971 Jul; 58(18):923-31. PubMed ID: 5095397
    [No Abstract]   [Full Text] [Related]  

  • 36. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
    Volkova LI; Shteĭngart IuN
    Klin Med (Mosk); 1994; 72(6):66-7. PubMed ID: 7898022
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].
    Dubiel JP; Cibor E; Bieron K; Zmuda A; Kostka-Trabka E
    Kardiol Pol; 1988; 31(10):626-32. PubMed ID: 3253452
    [No Abstract]   [Full Text] [Related]  

  • 39. Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
    Hsu K; Huang KL; Wang D; Hsu CS; Chiang CH
    Aviat Space Environ Med; 1997 Sep; 68(9):802-6. PubMed ID: 9293348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy].
    Schilling W
    Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.